Commission Implementing Regulation (EU) 2022/814 of 20 May 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval period of the active substance heptamaloxyloglucan
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
011/2023 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2022/814 of 20 May 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval period of the active substance heptamaloxyloglucan
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2022/814 frá 20. maí 2022 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilinu fyrir virka efnið heptamaloxýlóglúkan
Durchführungsverordnung (EU) 2022/814 der Kommission vom 20. Mai 2022 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Dauer der Genehmigung für den Wirkstoff Heptamaloxyloglucan
History
04.02.2023
Adopted JCD confirmed entry into force date
04.02.2023
Compliance date in the EEA
03.02.2023
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
14.12.2022
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
20.05.2022
Adoption date in the EU
26.05.2022
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.